CBD meets diabetes drugs: could this combo be a game changer for weight and sugar?

NCT ID NCT06648031

First seen Jan 12, 2026 · Last updated Jun 13, 2026 · Updated 25 times

Summary

This early-phase study tested a special form of cannabidiol (CBD) called DehydraTECH, alone or combined with GLP-1 drugs (like Ozempic), in 148 overweight or obese adults with prediabetes or type 2 diabetes. The main goal was to check safety and how the body processes the drugs, while also looking at effects on blood sugar and weight. Results will help decide if this combination deserves larger studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE2DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CMAX Clinical Research

    Adelaide, South Australia, 5000, Australia

  • Canopy Clinical Sutherland

    Miranda, New South Wales, 2228, Australia

  • Canopy Clinical Wollongong

    Wollongong, New South Wales, 2500, Australia

  • Emeritus - Melbourne

    Camberwell, Victoria, 3124, Australia

  • Emeritus - Sydney

    Botany, New South Wales, 2019, Australia

  • Paratus Clinical Brisbane Pty Ltd

    Herston, Queensland, 4006, Australia

  • Paratus Clinical Pty Ltd, Blacktown Trial Clinic

    Blacktown, New South Wales, 2148, Australia

Conditions

Explore the condition pages connected to this study.